KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Return on Equity (2016 - 2025)

Historic Return on Equity for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to 0.14%.

  • Regeneron Pharmaceuticals' Return on Equity fell 100.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.14%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.15% for FY2025, which is 100.0% down from last year.
  • Latest data reveals that Regeneron Pharmaceuticals reported Return on Equity of 0.14% as of Q4 2025, which was down 100.0% from 0.15% recorded in Q3 2025.
  • Regeneron Pharmaceuticals' Return on Equity's 5-year high stood at 0.46% during Q2 2021, with a 5-year trough of 0.14% in Q4 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.17% (2023), whereas its average is 0.24%.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Return on Equity surged by 1800bps in 2021 and then tumbled by -2500bps in 2022.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Return on Equity stood at 0.45% in 2021, then plummeted by -56bps to 0.2% in 2022, then dropped by -21bps to 0.16% in 2023, then decreased by -3bps to 0.15% in 2024, then decreased by -4bps to 0.14% in 2025.
  • Its Return on Equity stands at 0.14% for Q4 2025, versus 0.15% for Q3 2025 and 0.15% for Q2 2025.